Research Article
A Kinetic-Model-Based Approach to Identify Malfunctioning Components in Signal Transduction Pathways from Artificial Clinical Data
Table 6
Ranking of the possibility of the reactions whose downregulation causes the abnormal profiles shown in Figure 9(b) (Rxn16 is IKKaIκBα degradation; Rxn45 is release of IKK from IKKIκBαNF-κB complex; Rxn14 is IKKa and IκBα association; Rxn9 is IKK inactivation reaction caused by A20; and Rxn10 is IKK spontaneous inactivation).
|